Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| NOVAVAX | 9 | 7 | -0,91 % | ||
| INTELLIA THERAPEUTICS | 9 | 5 | +0,29 % | ||
| EDGEWISE THERAPEUTICS | 8 | 2 | 0,00 % | ||
| SYNDAX PHARMACEUTICALS | 8 | 1 | +0,57 % | ||
| AMNEAL PHARMACEUTICALS | 8 | - | +1,65 % | ||
| PERSONALIS | 8 | - | -7,07 % | ||
| VIATRIS | 7 | 2 | -1,35 % | ||
| MANNKIND | 7 | 2 | +1,64 % | ||
| CASTLE BIOSCIENCES | 7 | 2 | -2,96 % | ||
| PACIRA BIOSCIENCES | 7 | 1 | +3,65 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:34 | Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates | 1 | Zacks | ||
| 13:34 | ANI Pharma: EPS übertrifft Schätzungen um 0,36 $ - Umsatz besser als erwartet | 3 | Investing.com Deutsch | ||
| 13:18 | Oppenheimer raises Ligand Pharma stock price target on royalty outlook | 1 | Investing.com | ||
| 13:18 | Ionis presents new data on hereditary angioedema drug at AAAAI | 2 | Investing.com | ||
| 13:18 | Moderna's flu-COVID combo vaccine gets EU regulatory backing | 4 | Investing.com | ||
| 13:18 | Needham raises Personalis stock price target on reimbursement wins | 1 | Investing.com | ||
| 13:18 | Personalis stock price target reaffirmed at $13 by BTIG on MRD growth | 2 | Investing.com | ||
| 13:12 | Alvotech - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 13:10 | Oppenheimer hebt Kursziel für Ligand Pharma wegen starker Lizenzgebühren-Aussichten an | 1 | Investing.com Deutsch | ||
| 13:10 | Sanofi: Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment | 151 | GlobeNewswire (Europe) | Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
If approved, Dupixent would be the first... ► Artikel lesen | |
| 13:10 | Personalis: BTIG bestätigt Kursziel von 13 US-Dollar und setzt auf MRD-Wachstum | 1 | Investing.com Deutsch | ||
| 13:06 | Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment | 3 | GlobeNewswire (USA) | ||
| 13:06 | ANI Pharmaceuticals Non-GAAP EPS of $2.33 beats by $0.35, and revenue of $247.1M beats by $16.07M | 1 | Seeking Alpha | ||
| 13:06 | ANI Pharmaceuticals Q4 Earnings Assessment | 1 | Benzinga.com | ||
| 13:06 | Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise | 1 | Benzinga.com | ||
| 13:02 | Moderna, Inc.: European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 | 130 | ACCESS Newswire | mCOMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and represents Moderna's fourth vaccine to receive a positive... ► Artikel lesen | |
| 13:00 | ANI PHARMACEUTICALS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 12:58 | Amneal Pharma A: EPS übertrifft Schätzungen um 0,03 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 12:58 | Amneal übertrifft Q4-Prognosen, gibt aber verhaltenen Ausblick für 2026 | 1 | Investing.com Deutsch | ||
| 12:57 | ANI PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.